Updates to Roche’s Expanded Corporate Executive Committee
Roche announced today that James Sabry (born 1958), Head of Roche Pharma Partnering, will be retiring after fourteen years with the company. James Sabry joined Genentech in 2010 as Head…
BridgeBio Pharma to Share Further Insights on Acoramidis Study for Transthyretin Amyloid Cardiomyopathy at 2024 ISA Meeting
A biopharmaceutical company specializing in genetic diseases and cancers has unveiled plans to present a series of findings at the 2024 International Symposium on Amyloidosis (ISA) in Rochester, Minnesota, from…
Latest Findings: WAINUA (eplontersen) Study Results at 2024 ISA
Today, it was announced that new subgroup analyses from Ionis and AstraZeneca’s Phase 3 NEURO-TTRansform study of WAINUA™ (eplontersen) will be presented at the 2024 International Symposium on Amyloidosis (ISA)…
WHO Member States to Share Historic IHR, Pandemic Agreement Outcomes at World Health Assembly
After intensive negotiations, WHO Member States have concluded discussions aimed at enhancing global readiness for future pandemics and outbreaks following the COVID-19 crisis. They have agreed to present the outcomes…
Arrival of R21 Malaria Vaccine in Central African Republic: Advancing Child Survival
UNICEF has airlifted over 43,000 doses of the R21/Matrix-M malaria vaccine to Bangui, Central African Republic, marking a significant stride in combatting the disease and safeguarding children’s lives. This initial…
WHO’s Framework to Improve MPOX Prevention and Control
Monkeypox, a viral disease, continues its global impact. Today, the World Health Organization (WHO) unveiled a new strategic framework aimed at guiding efforts to prevent and manage monkeypox outbreaks. The…
COVID-19 Wipes Out Decade of Global Life Expectancy Gains
In the latest release of the World Health Statistics by the World Health Organization (WHO), the impact of the COVID-19 pandemic on global life expectancy and healthy life expectancy at…
Legend Biotech Showcases CAR-T Cell Therapy Leadership for Multiple Myeloma Patients at ASCO and EHA
Legend Biotech, a leading global cell therapy company, has announced the forthcoming presentation of new and updated data from its CARTITUDE clinical development program at the 2024 American Society of…
Eisai Unveils Oncology Portfolio and Pipeline at ASCO 2024
Eisai has announced its participation in the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (#ASCO24), held both virtually and in-person in Chicago, Illinois from May 31 to June…
UCB Announces Publication in The Lancet of Phase 3 Bimekizumab▼ Trials for Moderate to Severe Hidradenitis Suppurativa
UCB, a leading global biopharmaceutical company, has announced the publication of results from the Phase 3 BE HEARD I and BE HEARD II trials in The Lancet. These trials evaluated…
BRUKINSA Data Presented at ASCO Highlights Distinctive Clinical Efficacy for CLL and SLL Treatment
A global oncology company today announced the presentation of new analyses for BRUKINSA® (zanubrutinib) at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago from May 31 to…
Empowering Women in Clinical Trials: 5 Inspiring Quotes to Drive Change
Clinical Trials Day is globally recognized on May 20, and this year, the Walgreens Clinical Trials team celebrated with a special event dedicated to women’s health. Appropriately, May is National…